---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-089562"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:44:48.208591+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics appoints Jason D. Sawyer as Interim CEO under consulting agreement at $12,500/month

## Summary
- Jason D. Sawyer appointed Interim CEO via consulting agreement with Access Alternative Group S.A., effective Sept 4, 2025.
- Compensation set at $12,500 per month; agreement renewable month-to-month at Company's discretion.
- Company to indemnify Sawyer as CEO to fullest extent under Delaware law; D&O insurance maintained.
- Prior interim CEO appointment disclosed Sept 9; formal consulting agreement entered Sept 8.

## SEC filing metadata
- accession: 0001104659-25-089562
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/0001104659-25-089562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/tm2525441d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-089562
- JSON: https://secwatch.observer/filing/0001104659-25-089562.json
- Plain text: https://secwatch.observer/filing/0001104659-25-089562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.